295 related articles for article (PubMed ID: 15938721)
1. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
Bench AJ; Erber WN; Scott MA
Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
[TBL] [Abstract][Full Text] [Related]
2. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P
Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978
[TBL] [Abstract][Full Text] [Related]
3. The role of molecular genetic analysis within the diagnostic haemato-oncology laboratory.
Bench AJ
Int J Lab Hematol; 2012 Feb; 34(1):21-34. PubMed ID: 21883966
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.
Bench AJ; Erber WN; Follows GA; Scott MA
Int J Lab Hematol; 2007 Aug; 29(4):229-60. PubMed ID: 17617076
[TBL] [Abstract][Full Text] [Related]
5. Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies.
Gleissner B; Thiel E
Expert Rev Mol Diagn; 2001 Jul; 1(2):191-200. PubMed ID: 11901814
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of myeloproliferative neoplasms.
Patnaik MM; Tefferi A
Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
Drénou B; Fardel O; Fauchet R; Amiot L
Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic methods in the diagnosis of hematologic neoplasms.
Sen F; Vega F; Medeiros LJ
Semin Diagn Pathol; 2002 May; 19(2):72-93. PubMed ID: 12036283
[TBL] [Abstract][Full Text] [Related]
9. Contribution of multiparameter genetic analysis to the detection of genetic alterations in hematologic neoplasia. An evaluation of combining G-band analysis, spectral karyotyping, and multiplex reverse-transcription polymerase chain reaction (multiplex RT-PCR).
Preiss BS; Kerndrup GB; Pedersen RK; Hasle H; Pallisgaard N;
Cancer Genet Cytogenet; 2006 Feb; 165(1):1-8. PubMed ID: 16490591
[TBL] [Abstract][Full Text] [Related]
10. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH
Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224
[TBL] [Abstract][Full Text] [Related]
11. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
Bacher U; Kohlmann A; Haferlach T
Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of molecular haematology: an overview.
Bain BJ
J Assoc Physicians India; 2007 Jul; 55():503-6. PubMed ID: 17907501
[TBL] [Abstract][Full Text] [Related]
14. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
Anastasi J
Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
16. [Minimal residual disease in childhood acute leukemias].
Pawińska K; Balwierz W; Baran J
Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
[TBL] [Abstract][Full Text] [Related]
17. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of a hematologic cytogenetic laboratory to the diagnosis, classification and prognosis of various hematologic malignancies].
Debray J; Krulik M; Smadja NV
Bull Acad Natl Med; 1992 May; 176(5):629-38; discussion 638-40. PubMed ID: 1422868
[TBL] [Abstract][Full Text] [Related]
20. Jumping translocations in hematological malignancies: a cytogenetic study of five cases.
Manola KN; Georgakakos VN; Stavropoulou C; Spyridonidis A; Angelopoulou MK; Vlachadami I; Katsigiannis A; Roussou P; Pantelias GE; Sambani C
Cancer Genet Cytogenet; 2008 Dec; 187(2):85-94. PubMed ID: 19027489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
